Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-12-010594)

Filing Details

Accession Number:: 0001179110-12-010594
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-06-20 16:08:35
Reporting Period:: 2012-06-18

Filing Date:: 2012-06-20
Accepted Time:: 2012-06-20 16:08:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Synta Pharmaceuticals Corp	SNTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325714	E Wendy Rieder	C/O Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington MA 02421	Vp, Ip And Legal, Gen. Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-18	7,170	$2.49	26,993	No	4	M	Direct
Common Stock	Disposition	2012-06-18	7,170	$6.00	19,823	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2012-06-18	7,170	$0.00	7,170	$2.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,530		2019-04-13	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2011.
The option vested as to 50% of the shares on January 13, 2010 and as to the remaining 50% of the shares on October 13, 2010.